CREBBP.md
... ...
@@ -23,8 +23,8 @@ Mutations in CREBBP and EP300 affect a common pathway and have been described as
23 23
|:------:|:----:|--------------------------------------|
24 24
|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@parryWholeExomeSequencing2013] |
25 25
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@dunsCharacterizationDLBCLPMBL2021] |
26
-|![DLBCL](images/icons/DLBCL_tier1.png) |1-EE |high-confidence DLBCL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011] |
27
-|![FL](images/icons/FL_tier1.png) |1-EE |high-confidence FL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011] |
26
+|![DLBCL](images/icons/DLBCL_tier1.png) |1 |high-confidence DLBCL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011] |
27
+|![FL](images/icons/FL_tier1.png) |1 |high-confidence FL gene supported by functional data[@pasqualucciInactivatingMutationsAcetyltransferase2011] |
28 28
|![BL](images/icons/BL_tier2.png) |2 |association with BL is tenuous[@loveGeneticLandscapeMutations2012]|
29 29
30 30
## Mutation incidence in large patient cohorts (GAMBL reanalysis)